Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe revision/version identifier in the page footer has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check8 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Publications section with Quemliclustat and zimberelimab in metastatic pancreatic adenocarcinoma (Nat Med 2026) and PubMed notes. Updated Locations: removed Medical Oncology Associates (Spokane) and changed total locations from 14 to 13.SummaryDifference0.5%

- Check30 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page revision history.SummaryDifference0.0%

- Check51 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedUpdated the study locations: the page now lists 14 locations (as of 2026-02-27), replacing the previous 17-location listing and removing several sites.SummaryDifference0.5%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.